Oxygen therapy for cystic fibrosis

Area of Science:

• Pulmonary Medicine
• Critical Care Medicine

Background:

• Cystic Fibrosis (CF) complications primarily involve respiratory insufficiency.
• Oxygen therapy is a common treatment for hypoxemia in chronic lung diseases, including CF.
• Evidence supporting oxygen therapy indications in CF is limited, despite its costs and lifestyle impact.

Purpose of the Study:

• To evaluate the efficacy of oxygen therapy in improving longevity and quality of life for individuals with Cystic Fibrosis.

Main Methods:

• Systematic review of randomized or quasi-randomized controlled trials from the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register.
• Included studies compared oxygen administration (any concentration, route, duration) in individuals with documented CF.
• Data extraction and quality assessment were performed independently by two authors.

Main Results:

• Nine studies (149 participants) were reviewed; only one focused on long-term oxygen therapy.
• No significant improvements in survival, lung, or cardiac health were observed.
• Short-term oxygen improved oxygenation during sleep and exercise, but with modest hypercapnia and no significant sleep quality improvements. Exercise duration and peak performance showed some enhancement.

Conclusions:

• Current data do not support the prescription of chronic oxygen supplementation for advanced CF lung disease.
• Short-term oxygen therapy during sleep and exercise improves oxygenation but has limited clinical impact.
• Larger trials are needed to assess the benefits of continuous or intermittent long-term oxygen therapy in CF patients.